These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 12753302)
1. Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Thomas MC; Tikellis C; Burns WC; Thallas V; Forbes JM; Cao Z; Osicka TM; Russo LM; Jerums G; Ghabrial H; Cooper ME; Kantharidis P Kidney Int; 2003 Jun; 63(6):2152-61. PubMed ID: 12753302 [TBL] [Abstract][Full Text] [Related]
2. The role of advanced glycation in reduced organic cation transport associated with experimental diabetes. Thomas MC; Tikellis C; Kantharidis P; Burns WC; Cooper ME; Forbes JM J Pharmacol Exp Ther; 2004 Nov; 311(2):456-66. PubMed ID: 15213250 [TBL] [Abstract][Full Text] [Related]
3. Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes. Thomas MC; Jerums G; Tsalamandris C; Macisaac R; Panagiotopoulos S; Cooper ME; Kidney Int; 2005 Jun; 67(6):2494-9. PubMed ID: 15882297 [TBL] [Abstract][Full Text] [Related]
4. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625 [TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. Gilbert RE; Cox A; Wu LL; Allen TJ; Hulthen UL; Jerums G; Cooper ME Diabetes; 1998 Mar; 47(3):414-22. PubMed ID: 9519748 [TBL] [Abstract][Full Text] [Related]
6. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Tikellis C; Johnston CI; Forbes JM; Burns WC; Burrell LM; Risvanis J; Cooper ME Hypertension; 2003 Mar; 41(3):392-7. PubMed ID: 12623933 [TBL] [Abstract][Full Text] [Related]
7. Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats. Wiggins KJ; Tiauw V; Zhang Y; Gilbert RE; Langham RG; Kelly DJ Nephrology (Carlton); 2008 Dec; 13(8):721-9. PubMed ID: 18826488 [TBL] [Abstract][Full Text] [Related]
8. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Zimpelmann J; Kumar D; Levine DZ; Wehbi G; Imig JD; Navar LG; Burns KD Kidney Int; 2000 Dec; 58(6):2320-30. PubMed ID: 11115066 [TBL] [Abstract][Full Text] [Related]
9. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Yu XQ; Wu LL; Huang XR; Yang N; Gilbert RE; Cooper ME; Johnson RJ; Lai KN; Lan HY Kidney Int; 2000 Oct; 58(4):1469-80. PubMed ID: 11012882 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kelly DJ; Cox AJ; Tolcos M; Cooper ME; Wilkinson-Berka JL; Gilbert RE Kidney Int; 2002 Jan; 61(1):31-9. PubMed ID: 11786082 [TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. Li C; Yang CW; Park CW; Ahn HJ; Kim WY; Yoon KH; Suh SH; Lim SW; Cha JH; Kim YS; Kim J; Chang YS; Bang BK Kidney Int; 2003 Feb; 63(2):454-63. PubMed ID: 12631111 [TBL] [Abstract][Full Text] [Related]
14. [Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats]. Grima M; Anjuère J; Ingert C; Coquard C; Steger J; Barthelmebs M; Imbs JL Arch Mal Coeur Vaiss; 2001 Aug; 94(8):805-12. PubMed ID: 11575208 [TBL] [Abstract][Full Text] [Related]
15. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat. Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607 [TBL] [Abstract][Full Text] [Related]
16. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease. Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466 [TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition. Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Coughlan MT; Thallas-Bonke V; Pete J; Long DM; Gasser A; Tong DC; Arnstein M; Thorpe SR; Cooper ME; Forbes JM Endocrinology; 2007 Feb; 148(2):886-95. PubMed ID: 17110423 [TBL] [Abstract][Full Text] [Related]
19. Acute infusion of angiotensin II regulates organic cation transporters function in the kidney: its impact on the renal dopaminergic system and sodium excretion. Kouyoumdzian NM; Rukavina Mikusic NL; Robbesaul GD; Gorzalczany SB; Carranza A; Trida V; Fernández BE; Choi MR Hypertens Res; 2021 Mar; 44(3):286-298. PubMed ID: 32934369 [TBL] [Abstract][Full Text] [Related]
20. Identification of angiotensin converting enzyme 2 in the rodent retina. Tikellis C; Johnston CI; Forbes JM; Burns WC; Thomas MC; Lew RA; Yarski M; Smith AI; Cooper ME Curr Eye Res; 2004 Dec; 29(6):419-27. PubMed ID: 15764086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]